Refenesen Chest Congestion Relief
NDC Package 10956-381-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Refenesen Chest Congestion Relief is temporarily relieves symptoms associated with a cough ,the common cold,hay fever or other upper respiratory allergies.helps loosen phlegm;mucusclear nasal passagewaysloosens nasal congestiondrain bronchial tubesshrinks swollen membranesclears stuffy nosemakes coughs more productive. Marketed by Reese Pharmaceutical Co., this product is identified by NDC 10956-381 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
10956-381-50
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 50 TABLET in 1 BOTTLE, PLASTIC
Product Code
10956-381
11-Digit Billing Format
10956038150
RxNorm Crosswalk
  • RxCUI: 1304111 - guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet
  • RxCUI: 1304111 - guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet

Clinical Specifications

Proprietary Name
Refenesen Chest Congestion Relief PE
Dosage Form
-
Usage Information
Temporarily relieves symptoms associated with a cough ,the common cold,hay fever or other upper respiratory allergies.helps loosen phlegm;mucusclear nasal passagewaysloosens nasal congestiondrain bronchial tubesshrinks swollen membranesclears stuffy nosemakes coughs more productive

Regulatory & Marketing

Labeler Name
Reese Pharmaceutical Co.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
09-25-2014
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (10956-381). Click a package code to view its specific billing and regulatory data.

10956-381-09
1 BOTTLE, PLASTIC in 1 CARTON / 100 TABLET in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10956-381-50 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 50 tablet in 1 bottle, plastic of Refenesen Chest Congestion Relief PE, labeled by Reese Pharmaceutical Co.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Reese Pharmaceutical Co. on September 25, 2014. The current certification is valid through December 31, 2019.

How is this Reese Pharmaceutical Co. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10956038150. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
10956-381-50
11-Digit CMS (5-4-2)
10956-0381-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.